Watch Ticker

Foghorn Therapeutics Inc. Common Stock

Go to Foghorn Therapeutics Inc. Common Stock Website

$4.92

-0.08 (-1.60%)

Live

Previous Close

Day Range

$0 - $0

Previous Day Range

$4.965 - $5.24

Market Cap

$286.5 million USD

Day Vol.

Previous Day Vol.

105579

Currency

USD

Primary Exchange

Nasdaq

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Foghorn Therapeutics Inc. - Foghorn Therapeutics Provides Second Quarter 2025 Financial and Corporate Update

Foghorn Therapeutics reports progress on its oncology drug development pipeline, including the FHD-909 Phase 1 trial for SMARCA4 mutated cancers and advancing selective degrader programs targeting CBP, EP300, and ARID1B, with a strong cash position of $198.7 million through 2028.

Related tickers: FHTX, LLY.

Read Full Article

N/A - Foghorn Therapeutics Appoints Neil Gallagher and Stuart Duty to its Board of Directors

Foghorn Therapeutics, a clinical-stage biotechnology company, announced the election of Neil Gallagher, M.D., Ph.D., and Stuart Duty to its Board of Directors. The new board members bring extensive experience in the biotechnology industry and will provide strategic insights to help advance Foghorn's pipeline.

Related tickers: FHTX.

Read Full Article

Trending Tickers

Please sign in to view